Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Analytical Biochemistry
|
September 6, 2020
Magnetic particle transport through organogel - an application to DNA extraction
Tetsuo Ohashi, Hiroki Kuyama
Clinical Rheumatology
|
November 11, 2016
Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study
Tatsuo Hosoya, Tomomitsu Sasaki, Tetsuo Ohashi
Biomedical Microdevices
|
May 17, 2007
A simple device using magnetic transportation for droplet-based PCR
Tetsuo Ohashi, Hiroki Kuyama, Nobuhiro Hanafusa, et al.
Clinical and Experimental Nephrology
|
November 18, 2019
The effect for hyperuricemia inpatient of uric acid overproduction type or in combination with topiroxostat on the pharmacokinetics, pharmacodynamics and safety of dotinurad, a selective urate reabsorption inhibitor
Daisuke Okui, Tomomitsu Sasaki, Masahiko Fushimi, et al.
Analytica Chimica Acta
|
March 25, 2008
Control of aqueous droplets using magnetic and electrostatic forces
Tetsuo Ohashi, Hiroki Kuyama, Koichi Suzuki, et al.
Clinical Biomechanics (Bristol, Avon)
|
August 16, 2005
Evaluation of the effect of collagen network degradation on the frictional characteristics of articular cartilage using a simultaneous analysis of the contact condition
Marco Hiroshi Naka, Koji Hattori, Tetsuo Ohashi, et al.
Clinical and Experimental Nephrology
|
January 26, 2020
Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study
Tatsuo Hosoya, Takafumi Sano, Tomomitsu Sasaki, et al.
Clinical and Experimental Nephrology
|
December 27, 2019
Open-label study of long-term administration of dotinurad in Japanese hyperuricemic patients with or without gout
Tatsuo Hosoya, Masahiko Fushimi, Daisuke Okui, et al.
Clinical and Experimental Nephrology
|
January 1, 2020
Clinical pharmacological study of dotinurad administered to male and female elderly or young subjects
Hiroshi Nakatani, Masahiko Fushimi, Tomomitsu Sasaki, et al.
Clinical and Experimental Nephrology
|
December 4, 2019
Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study
Tatsuo Hosoya, Takafumi Sano, Tomomitsu Sasaki, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Analytical Biochemistry
|
September 6, 2020
Magnetic particle transport through organogel - an application to DNA extraction
Tetsuo Ohashi, Hiroki Kuyama
Clinical Rheumatology
|
November 11, 2016
Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study
Tatsuo Hosoya, Tomomitsu Sasaki, Tetsuo Ohashi
Biomedical Microdevices
|
May 17, 2007
A simple device using magnetic transportation for droplet-based PCR
Tetsuo Ohashi, Hiroki Kuyama, Nobuhiro Hanafusa, et al.
Clinical and Experimental Nephrology
|
November 18, 2019
The effect for hyperuricemia inpatient of uric acid overproduction type or in combination with topiroxostat on the pharmacokinetics, pharmacodynamics and safety of dotinurad, a selective urate reabsorption inhibitor
Daisuke Okui, Tomomitsu Sasaki, Masahiko Fushimi, et al.
Analytica Chimica Acta
|
March 25, 2008
Control of aqueous droplets using magnetic and electrostatic forces
Tetsuo Ohashi, Hiroki Kuyama, Koichi Suzuki, et al.
Clinical Biomechanics (Bristol, Avon)
|
August 16, 2005
Evaluation of the effect of collagen network degradation on the frictional characteristics of articular cartilage using a simultaneous analysis of the contact condition
Marco Hiroshi Naka, Koji Hattori, Tetsuo Ohashi, et al.
Clinical and Experimental Nephrology
|
January 26, 2020
Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study
Tatsuo Hosoya, Takafumi Sano, Tomomitsu Sasaki, et al.
Clinical and Experimental Nephrology
|
December 27, 2019
Open-label study of long-term administration of dotinurad in Japanese hyperuricemic patients with or without gout
Tatsuo Hosoya, Masahiko Fushimi, Daisuke Okui, et al.
Clinical and Experimental Nephrology
|
January 1, 2020
Clinical pharmacological study of dotinurad administered to male and female elderly or young subjects
Hiroshi Nakatani, Masahiko Fushimi, Tomomitsu Sasaki, et al.
Clinical and Experimental Nephrology
|
December 4, 2019
Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study
Tatsuo Hosoya, Takafumi Sano, Tomomitsu Sasaki, et al.
Page
of 2